MiMedx Group Inc Stock Nasdaq
Equities
US6024961012
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.195 USD | +156.96% | -52.57% | -76.61% |
Apr. 30 | Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M | MT |
Financials (USD)
Sales 2024 * | 361M | Sales 2025 * | 406M | Capitalization | 1.06B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 55M | EV / Sales 2024 * | 2.94 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.62 x |
P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
19.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.76% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 23-01-26 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 23-07-04 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 20-07-01 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 21-03-07 |
K. Newton
BRD | Director/Board Member | 61 | 19-06-18 |
1st Jan change | Capi. | |
---|---|---|
-21.29% | 129M | |
+3.19% | 71.46M | |
+5.15% | 60.45M | |
-1.20% | 51.85M |